Drug Profile
SAB 136
Alternative Names: SAB-136Latest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator SAB Biotherapeutics
- Class Antibacterials; Polyclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mycoplasma infections